Skip to main content

Advertisement

SpringerLink
Log in

Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis

  • Brief Report
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

In terms of eradication, osteomyelitis represents one of the most challenging infective conditions in medicine and surgery. In recent years, the use of bioactive glass in conjunction with antimicrobial therapy has emerged as a viable new treatment.

Aim

We present a short study, from a regional orthopaedic unit, demonstrating its successful use in three patients with chronic osteomyelitis.

Methods

Between September 2010 and May 2011, bioactive glass S53P4 was used in conjunction with intravenous and oral antibiotics to treat chronic osteomyelitis in three patients (two male, one female). All patients underwent debridement and sequestrectomy procedures with the insertion of bioactive glass followed by antimicrobial regimens tailored to isolated pathogen sensitivities. Patient age ranged from 28 to 68 years, with a mean age of 44.7 years. The presentation period, from time of initial diagnosis to treatment, varied from 16 months to 16 years and all three patients had underwent multiple previous debridements and antimicrobial regimens to no avail.

Results

A follow-up of 14–21 months has been achieved with a mean follow-up of 17.3 months. We have seen excellent results in all three patients. All haematological and biochemical parameters have returned to normal, pain has ceased and function has returned in the affected limbs. All antibiotics have stopped and there is no radiological evidence of osteomyelitis. The bioactive glass has integrated with the surrounding bone.

Conclusions

Though a relatively recent development, bioactive glass used in concurrence with antibiotic therapy has significant potential in the treatment of chronic osteomyelitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lindfors NC et al (2010) Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 47:212–218

    Article  PubMed  CAS  Google Scholar 

  2. Paluska SA (2004) Osteomyelitis. Clin Family Prac 6:127–156

    Article  Google Scholar 

  3. Konttinen YT et al (2001) Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. J Bone Miner Res 16:1780–1786

    Article  PubMed  CAS  Google Scholar 

  4. Geurts J et al (2011) Bone graft substitutes in active or suspected infection. Contra-indicated or not? Injury 42:S82–S86

    Article  PubMed  Google Scholar 

  5. Hench LL et al (1971) Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 5(6):117–141

    Article  Google Scholar 

  6. Rahaman MN et al (2011) Bioactive glass in tissue engineering. Acta Biomater 7:2355–2373

    Article  PubMed  CAS  Google Scholar 

  7. Stoor P et al (1999) Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism Klebsiella ozaenae. J Biomed Mater Res 48:869–874

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Midland Regional Hospital, Tullamore, County Offaly, Ireland

    J. McAndrew, C. Efrimescu, E. Sheehan & D. Niall

Authors
  1. J. McAndrew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Efrimescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Niall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. McAndrew.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McAndrew, J., Efrimescu, C., Sheehan, E. et al. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. Ir J Med Sci 182, 509–511 (2013). https://doi.org/10.1007/s11845-012-0895-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-012-0895-5

Keywords

Search

Navigation